from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2961/-

LFCtreatmentdescriptionclass of inhibitor

-0.306

Amikacinug/mL Amikacintranslation

0.110

Cap5-10ug/mL Capreomycintranslation

0.077

Rox10-50 ug/mL Roxithromycintranslation

-0.521

SM2-5 ug/mL Streptomycintranslation

0.065

Tet5-10 ug/mL Tetracyclinetranslation

-0.479

Rif0.2-5ug/mL Rifampicintranscription

-0.566

Rifp0.1-0.5ug/mL Rifapentinetranscription

5.565

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.569

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.799

CPZ10-50 ug/mL Chlorpromazinerespiration

0.651

Clofazimine10-13 ug/mL Clofaziminerespiration

0.051

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.693

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.341

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.322

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.073

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.721

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.005

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.915

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.335

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.921

KCN5-20 ug/mL Potassium cyaniderespiration

-0.676

NaN30.2-2 mM Sodium aziderespiration

-0.490

Nigericin50 uM Nigericinrespiration

1.254

TRC10-150 ug/mL Triclosanrespiration

0.583

TRZ10-25 ug/mL Thioridazinerespiration

0.969

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.305

menadione6-10 ug/mL Menadionerespiration

-0.154

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.605

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.497

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.251

NRP_1Non-replicating persistence stage 1dosRassociated

-0.147

Amp0.2mg/mL AmpicillincellWall

-0.417

Cephalexin20-100 ug/mL CephalexincellWall

-0.220

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.546

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.286

EMB10-20 ug/mL EthambutolcellWall

-0.546

Eta12-40 ug/mL EthionamidecellWall

-0.338

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.097

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.989

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.287

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.004

BZA0.12 mg/mL BenzamidearomaticAmides

0.197

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.250

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.643

H2O24 mM hydrogen peroxideDNAdamaging

-0.120

Levo10 ug/mL LevofloxacinDNAdamaging

-0.493

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.892

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.156

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.416

UVUV-irradiationDNAdamaging

0.114

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.103

Antimycin12.5-50 ug/mL Antimycin A?

-0.244

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.438

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.426

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.570

PA8240.2-2 ug/mL PA-824?

-1.178

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.621

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.858

Verapamil50 uM Verapamil?

0.025

mercaptoethanol2 mM 2-Mercaptoethanol?

0.239

methoxatin10-20 ug/mL Methoxatin?